Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders: Regulation of dopaminergic neural transmission by tyrosine hydroxylase protein at nerve terminals

Journal of Pharmacological Sciences

Volumn 114, Issue 1, 2010, Pages 17-24

  Sumi Ichinose, Chiho ^a   Ichinose, Hiroshi ^b   Ikemoto, Kazuhisa ^a   Nomura, Takahide ^a   Kondo, Kazunao ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Dopamine; Dystonia; Striatum; Tetrahydrobiopterin; Tyrosine hydroxylase

Indexed keywords

5 LEVO ERYTHRO 5,6,7,8 TETRAHYDROBIOPTERIN; 6 PYRUVOYLTETRAHYDROPTERIN SYNTHASE; COMPLEMENTARY DNA; DOPAMINE; DOPAMINE BETA MONOOXYGENASE; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; TETRAHYDROBIOPTERIN; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ARTICLE; CELL LEVEL; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; DRUG RESEARCH; DYSTONIA; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; MENTAL DISEASE; MOTOR DYSFUNCTION; MUTATIONAL ANALYSIS; NERVE ENDING; NEUROMODULATION; NEUROPATHOLOGY; NONHUMAN; PROMOTER REGION; SEGAWA DISEASE; SIGNAL TRANSDUCTION;

EID: 77957953665     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.09R28FM     Document Type: Article

References (38)

1. Thöny B, Auerbach G, Blau N. Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem J. 2000;347:1-16.
2. Kwon NS, Nathan CF, Stuehr DJ. Reduced biopterin as a cofactor in the generation of nitrogen oxides by murine macrophages. J Biol Chem. 1989;264:20496-20501.
3. Garthwaite J, Charles SL, Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature. 1988;336:385-388.
4. Bogdan C. Nitric oxide and the immune response. Nat Immunol. 2001;2:907-916.
5. Förstermann U, Münzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation. 2006;113:1708-1714.
6. Vásquez-Vivar J, Kalyanaraman B, Martásek P, Hogg N, Masters BSS, Karoui H, et al. Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors. Proc Natl Acad Sci U S A. 1998;95:9220-9225.
7. Longo N. Disorders of biopterin metabolism. J Inherit Metab Dis. 2009;32:333-342.
8. Segawa M, Hosaka A, Miyagawa F, Nomura Y, Imai H. Hereditary progressive dystonia with marked diurnal fluctuation. In: Advances in neurology. Eldridge R, Farn S, editors, Vol. 14, New York: Raven Press; 1976. p. 215-233.
9. Ichinose H, Ohye T, Takahashi E, Seki N, Hori T, Segawa M, et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet. 1994;8:236-242.
10. Furukawa Y, Nygaard TG, Gütlich M, Rajput AH, Pifl C, DiStefano L, et al. Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia. Neurology. 1999;53:1032-1041.
11. Blau N, Thöny B, Heizmann CW, Dhondt JL. Tetrahydrobiopterin deficiency: From phenotype to genotype. Pteridines. 1993;4:1-10.
12. Sumi-Ichinose C, Urano F, Kuroda R, Ohye T, Kojima M, Tazawa M, et al. Catecholamines and serotonin are differently regulated by tetrahydrobiopterin. A study from 6-pyruvoyltetrahydropterin synthase knockout mice. J Biol Chem. 2001;276:41150-41160.
13. Elzaouk L, Leimbacher W, Turri M, Ledermann B, Burki K, Blau N, et al. Dwarfism and low insulin-like growth factor-1 due to dopamine depletion in Pts-/- mice rescued by feeding neurotransmitter precursors and H4-biopterin. J Biol Chem. 2003;278:28303-28311.
14. Sumi-Ichinose C, Urano F, Shimomura A, Sato T, Ikemoto K, Shiraishi H, et al. Genetically rescued tetrahydrobiopterin-depleted mice survive with hyperphenylalaninemia and regionspecific monoaminergic abnormalities. J Neurochem. 2005;95:703-714.
15. Mercer EH, Hoyle GW, Kapur RP, Brinster RL, Palmiter RD. The dopamine beta-hydroxylase gene promoter directs expression of E. coli lacZ to sympathetic and other neurons in adult transgenic mice. Neuron. 1991;7:703-716.
16. Kobayashi K, Morita S, Mizuguchi T, Sawada H, Yamada K, Nagatsu I, et al. Functional and high level expression of human dopamine beta-hydroxylase in transgenic mice. J Biol Chem. 1994;269:29725-29731.
17. Sato K, Sumi-Ichinose C, Kaji R, Ikemoto K, Nomura T, Nagatsu I, et al. Differential involvement of striosome and matrix dopamine systems in a transgenic model of dopa-responsive dystonia. Proc Natl Acad Sci U S A. 2008;105:12551-12556.
18. Shashidharan P, Sandu D, Potla U, Armata IA, Walker RH, McNaught KS, et al. Transgenic mouse model of early-onset DYT1 dystonia. Hum Mol Genet. 2005;14:125-133.
19. Graybiel AM, Canales JJ, Capper-Loup C. Levodopa-induced dyskinesias and dopamine-dependent stereotypies: a new hypothesis. Trends Neurosci. 2000;23:S71-S77.
20. Canales JJ, Graybiel AM. A measure of striatal function predicts motor stereotypy. Nat Neurosci. 2000;3:377-383.
21. Thöny B, Calvo AC, Scherer T, Svebak RM, Haavik J, Blau N, et al. Tetrahydrobiopterin shows chaperone activity for tyrosine hydroxylase. J Neurochem. 2008;106:672-681.
22. Okuno S, Fujisawa H. Conversion of tyrosine hydroxylase to stable and inactive form by the end products. J Neurochem. 1991;57:53-60.
23. Urano F, Hayashi N, Arisaka F, Kurita H, Murata S, Ichinose H. Molecular mechanism for pterin-mediated inactivation of tyrosine hydroxylase: formation of insoluble aggregates of tyrosine hydroxylase. J Biochem. 2006;139:625-635.
24. Haavik J, Mmartinez A, Flatmark T. pH-dependent release of catechlamines from tyrosine hydroxylase and the effect of phosphorylation of Ser40. FEBS Lett. 1990;262:363-365.
25. Hyland K, Gunasekera RS, Engle T, Arnold LA. Teterahydrobiopterin and biogenic amine metabolism in the hph-1 mouse. J Neurochem. 1996;67:752-759.
26. Brand MP, Heales SJR, Land JM, Clark JB. Tetrahydrobiopterin deficiency and brain nitric oxide synthase in the hph1 mouse. J Inher Metab Dis. 1995;18:33-39.
27. Yang S, Lee YJ, Kim JM, Park S, Peris J, Laipis P, et al. A murine model for human sepiapterin-reductase deficiency. Am J Hum Genet. 2006;78:575-587.
28. Takazawa C, Fujimoto K, Homma D, Sumi-Ichinose C, Nomura T, Ichinose H,et al. A brain-specific decrease of the tyrosine hydroxylase protein in sepiapterin reductase-null mice -as a mouse model for Parkinson's disease. Biochem Biophys Res Commun. 2008;367:787-792.
29. Pastor CM, Williams D, Yoneyama T, Hatakeyama K, Singleton S, Naylor E, et al. Competition for tetrahydrobiopterin between phenylalanine hydroxylase and nitric oxide synthase in rat liver. J Biol Chem. 1996;271:24534-24538.
30. Davis MD, Ribeiro P, Tipper J, Kaufman S. "7-Tetrahydrobiopterin," a naturally occurring analogue of tetrahydrobiopterin, is a cofactor for and a potential inhibitor of the aromatic amino acid hydroxylases. Proc Natl Acad Sci U S A. 1992;89:10109-10113.
31. Zorzi G, Thöny B, Blau N. Reduced nitric oxide metabolites in CSF of patients with tetrahydrobiopterin deficiency. J Neurochem. 2002;80:326-364.
32. Hawkins RA, O'Kane RL, Simpson IA, Viña JR. Structure of the blood-brain barrier and its role in the transport of amino acids. J Nutr. 2006;136:218S-226S.
33. Ogawa S, Ichinose H. Effect of metals and phenylalanine on the activity of human tryptophan hydroxylase-2: Comparison with that on tyrosine hydroxylase activity. Neurosci Lett. 2005;401:261-265.
34. Graybiel AM, Ohta K, Roffler-Tarlov S. Patterns of cell and fiber vulnerability in the mesostriatal system of the mutant mouse weaver. I. Gradients and compartments. J Neurosci. 1990;10:720-733.
35. Hornykiewicz O. Striatal dopamine in dopa-responsive dystonia: comparison with idiopathic Parinson's disease and other dopamine- dependent disorders. In: Segawa M, Nomura Y, editors. Monogr neural science. Basel: Karger; 1995. p. 101-108.
36. Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med. 1988;318:876-880.
37. Hamasaki T, Goto S, Nishikawa S, Ushio Y. Neuronal cell migration for the developmental formation of the mammalian striatum. Brain Res Brain Res Rev. 2003;41:1-12.
38. Kim DS, Froelick GJ, Palmiter RD. Dopamine-dependent desensitization of dopaminergic signaling in the developing mouse striatum. J Neurosci. 2002;22:9841-9849.